Gland Pharma Limited has announced its 48th Annual General Meeting (AGM) scheduled for Tuesday, August 25, 2026. The meeting will be conducted via video conference. Key agenda items include the adoption of audited financial statements for the year ended March 31, 2026, declaration of a final dividend of ₹20 per equity share, and the reappointment of directors Mr. Wenjie Zhang and Ms. Wei Huang. E-voting will be open from August 22 to August 24, 2026.
48th AGM Details
Gland Pharma Limited will hold its 48th Annual General Meeting (AGM) on Tuesday, August 25, 2026. The meeting will be conducted through video conference/Other Audio-Visual Means (OAVM) at 11:00 AM IST.
Key Agenda Items
Ordinary Business:
1. To receive, consider and adopt the audited Standalone Financial Statements of the Company for the Financial Year ended 31st March, 2026.
2. To receive, consider and adopt the audited Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2026.
3. To declare the final dividend on equity shares for the financial year ended 31st March 2026. The Board has recommended a final dividend of ` 20/- (INR Twenty only) per equity share.
4. To reappoint Mr. Wenjie Zhang as a Director, liable to retire by rotation and being eligible, offers himself for reappointment.
5. To reappoint Ms. Wei Huang as a Director, liable to retire by rotation and being eligible, offers herself for reappointment.
E-voting Information
The cut-off date for e-voting is Tuesday, August 18, 2026. E-voting will commence on Saturday, August 22, 2026, at 9:00 AM IST and end on Monday, August 24, 2026, at 5:00 PM IST. Members can cast their votes electronically on the NSDL website: https://www.evoting.nsdl.com/.
Source: BSE
